Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: A Sleep Intervention (SLEEP-Extend) for Young Adults At-Risk for Type 2 Diabetes [NA]
Completed clinical trial (SLEEP-Extend) evaluating a sleep intervention for young adults at risk of type 2 diabetes; results posted in 2019.
-
FDA approval · 2019-12-27FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2019-12-24Clinical Trial Update: Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial comparing oral semaglutide to empagliflozin in adults with type 2 diabetes mellitus; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: Incidence of Major Cardiovascular Events in Diabetic Patients With ACS Undergoing Coronary Angioplasty and Treated With Clopidogrel 150 mg Versus 75 mg [Phase 4]
A Phase 4 trial comparing high (150 mg) versus standard (75 mg) clopidogrel in diabetic patients with NSTEMI undergoing coronary angioplasty…
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes [Phase 2]
Phase 2 safety and tolerability trial of MEDI0382 in Japanese preobese or obese subjects with Type 2 diabetes completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: Sitagliptin for Hyperglycemia in Patients With T2DM Undergoing Cardiac Surgery [Phase 4]
Phase 4 trial evaluating sitagliptin for hyperglycemia in patients with type 2 diabetes undergoing cardiac surgery has completed with result…
-
FDA approval · 2019-12-20FDA Approved: GLIPIZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for glipizide from ANI Pharmaceuticals, Inc., authorizing changes to an already approved product…
-
FDA approval · 2019-12-19FDA Approved: FIASP — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for FIASP (insulin aspart injection) from Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin [Phase 3]
Phase 3 trial update on dapagliflozin indicating paradoxical stimulation of hepatic glucose production; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-12-18Clinical Trial Update: SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2 [Phase 3]
Phase 3 clinical trial update on SGLT2 inhibition and stimulation of endogenous glucose production in type 2 diabetes; study completed with …
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes [Phase 3]
Phase 3 trial comparing semaglutide to canagliflozin as add-on to metformin in adults with type 2 diabetes; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study [Phase 2]
An completed Phase 2 clinical trial update for a study in adolescents with type 2 diabetes exploring outcomes related to obesity and abnorma…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Effects of Linagliptin on Endothelial Function [Phase 4]
Phase 4 trial assessing the effects of linagliptin on endothelial function in patients with type 2 diabetes and coronary artery disease.
-
FDA approval · 2019-12-13FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a Supplemental Application for Bromocriptine Mesylate by ANI Pharmaceuticals, Inc. The provided excerpt does not specify a new …
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes [Phase 1]
Phase 1 clinical trial of single and repeated doses of glucagon in participants with diabetes was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-11Clinical Trial Update: Dapagliflozin vs Empagliflozin on Flow Mediated Dilation in Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial comparing dapagliflozin vs empagliflozin on flow-mediated dilation in type 2 diabetes mellitus; current status unknown.
-
EMA guidance · 2019-12-06EMA update on metformin diabetes medicines
EMA provides an update on metformin-containing diabetes medicines, outlining current assessments and recommendations related to safety and u…
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics [Phase 4]
Phase 4 trial update evaluating escalating oral vitamin D replacement on insulin resistance (HOMA-IR) in vitamin D–deficient individuals wit…
-
CLINICAL_TRIALS trial_result · 2019-12-03Clinical Trial Update: Effects of Dapagliflozin on Central Hemodynamics and Urine Albumin Excretion in Patients With Type 2 Diabetes. [Phase 4]
Phase 4 trial update on dapagliflozin assessing effects on central hemodynamics and urine albumin excretion in type 2 diabetes patients; stu…
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin [Phase 4]
Phase 4 trial comparing canagliflozin and sitagliptin to assess glucose variability in Mexican participants with type 2 diabetes inadequatel…
-
FDA approval · 2019-11-27FDA Approved: OZEMPIC — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for OZEMPIC (semaglutide) from Novo Nordisk. The approval updates the drug's labeling or indicat…
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin [Phase 3]
Phase 3 trial evaluating liraglutide 3.0 mg for weight management in overweight/obesity with type 2 diabetes on basal insulin; study complet…
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: FAMS Mobile Health Intervention for Diabetes Self-care Support [NA]
Clinical trial update for a mobile health intervention (FAMS) aimed at diabetes self-care support; study completed with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus [Phase 3]
A 104-week Phase 3 trial comparing long-term glycemic control of IDegLira versus insulin glargine in adults with type 2 diabetes; results po…
-
CLINICAL_TRIALS trial_result · 2019-11-27Clinical Trial Update: Fatty Acid Radiotracer Comparison Study in Heart Failure Patients [EARLY_Phase 1]
A Phase 1 early trial comparing fatty acid radiotracers in heart failure patients has completed with results posted.